Tivozanib: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-017-0825-y
Published Online: 2017-10-03
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Esther S.
License valid from 2017-10-03